December 3 (SeeNews) - US-based pharmaceutical company Pfizer and German biotechnology company BioNTech have applied for the registration of their COVID-19 vaccine in Serbia, a representative of Serbia's Medicines and Medical Devices Agency said.
"Our experts are already analysing the documents submitted by Pfizer and BioNTech," the public relations director of the agency, Pavle Zelic, said in a video file posted on the YouTube channel of public broadcaster RTS on Wednesday.
Last month, Serbian president Aleksandar Vucic said Serbia agreed the delivery of 1.8 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech by the end of 2021, and was also in talks with UK-based AstraZeneca, as well as Russian and Chinese companies for the supply of vaccines.
"Our wish is to have several vaccines available that we will be able to critically evaluate, we hope to have several vaccines very soon," Zelic said.